RMD · Healthcare
What a holder would want to know before buying RMD: where the price sits in its own history, how far it has fallen before and whether it recovered, and what the business behind it earns. All of it is arithmetic over free market data — no opinions, no recommendations.
Today’s price is 26% above the lowest point of the past year and 17% below the highest.
Over the past year it was cheaper than today on 51% of days and more expensive on 49%. Over the last 10 years: cheaper on 76% of days.
2% above its average price of the last 200 trading days.
Fell 20% or more 3 times in 10 years. The deepest fall was 55%; the longest took 5 months to get back to its peak. 2 of 3 have recovered so far.
It is in one now: 23% below the Sep 2021 peak.
ResMed Inc. · Healthcare · Medical Instruments & Supplies · a large company worth $32.35B
ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software.…
revenue profit
Sales of $5.65B in 2026, with $1.52B of profit. Sales grew in 3 of the last 3 years.
Keeps about 27 cents of every dollar of sales as profit.
Generates more free cash in a year ($939.25M) than it owes in total ($825.92M).
You pay $22 for every $1 of last year’s profit, and $17 for every $1 of profit expected next year.
A high number means buyers expect growth; a low one means they expect little, or fear trouble. Large US companies have averaged roughly 15–20 over the decades.
Pays 1.16% a year in dividends at today’s price · next ex-dividend Aug 20.
20 analysts: 9 say buy, 10 hold, 1 sell. Their average 12-month target is $250.22 (range $175.00–$320.00).
Insiders made 0 purchases and 6 sales in the last 6 months. Executives routinely sell shares they were paid in; buying with their own money is the rarer signal.
Free data from Yahoo Finance, refreshed daily. This is evidence about the business and its price history, not a recommendation.
Poshkan is paper trading: real prices, virtual money. Buy RMD with $10,000 that isn’t real, set a stop before you enter, and find out what your idea would actually have done.
Data from Yahoo Finance, refreshed hourly. Nothing here is financial advice. Poshkan is a paper-trading simulator — all money, trades and returns are virtual.